Results 1 - 10 of 304
[PROJECT] OPTIMUNISE - Optimising the impact and cost-effectiveness of child health intervention programmes of vaccines and micronutrients in low-income countries
ID: 261375
Start date: 2011-03-01, End date: 2016-08-31
International child health programmes in low-income countries are justified in term of their impact on child survival. However, the effect estimates are usually calculated from performance indicators and assumptions about efficacy based on small-scale target-specific studies....
Programme: FP7-HEALTH
Record Number: 98247
Last updated on: 2017-05-26
[PROJECT] EUROCANPLATFORM - A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-05-29
[PROJECT] RATHER - Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
ID: 258967
Start date: 2011-01-01, End date: 2018-06-30
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. While there are several ongoing large-scale genome re-sequen...
Programme: FP7-HEALTH
Record Number: 97660
Last updated on: 2017-07-16
[PROJECT] ASFRISK - Evaluating and controlling the risk of African swine fever in the EU
ID: 211691
Start date: 2008-04-01, End date: 2011-09-30
African swine fever (ASF) in EU member states is currently confined to Italy (Sardinia), it was recently introduced to Caucasian regions and it is highly prevalent in sub-Saharan African countries. In both the EC and Africa changes in the epidemiology of the disease have rece...
Programme: FP7-KBBE
Record Number: 88394
Last updated on: 2017-05-29
[PROJECT] IDEAL - Integrated research on DEvelopmental determinants of Aging and Longevity
ID: 259679
Start date: 2011-02-01, End date: 2016-01-31
IDEAL will obtain insight into the role of early life conditions affecting late-life health, disease and aging, and the role of epigenetic regulation therein. IDEAL will identify the determinants and targets of this epigenetic regulation utilizing a resource of unique human c...
Programme: FP7-HEALTH
Record Number: 98424
Last updated on: 2017-07-12
[REPORT SUMMARY] Final Report Summary - EUTRAF (The European Network for Translational Research in Atrial Fibrillation)
Executive Summary:The EUTRAF project was a unique European Network of highly successful investigators who have common interest in the pathophysiology and treatment of AF. By integrating the mutually complementary strengths and expertise from molecular and cellular...
Programme: FP7-HEALTH
Record Number: 183644
Last updated on: 2016-06-06
[PROJECT] EUTRAF - The European Network for Translational Research in Atrial Fibrillation
ID: 261057
Start date: 2010-11-01, End date: 2015-10-31
The initiation and perpetuation of atrial fibrillation (AF) can be regarded as a complication of a progressive transformation of the structure and functional properties of the atria. This transformation is the result of complex and multiple changes at the molecular, cellular ...
Programme: FP7-HEALTH
Record Number: 96749
Last updated on: 2017-07-12
[PROJECT] METOXIA - Metastatic tumours facilitated by hypoxic tumour micro-environments
ID: 222741
Start date: 2009-02-01, End date: 2014-07-31
Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermore, hypoxic tumour micro-environments may result in treatment resistance of cancer cells, therefore causing a double effect of reducing ...
Programme: FP7-HEALTH
Record Number: 91061
Last updated on: 2017-07-12
[PROJECT] ANTIFLU - Innovative anti-influenza drugs excluding viral escape
ID: 259842
Start date: 2011-06-01, End date: 2016-11-30
ANTIFLU is to develop innovative drugs against influenza virus infections based on a novel concept that precludes the development of viral resistance and ensures efficacy against upcoming pandemic influenza strains. Viral replication is known to depend on multiple host factor...
Programme: FP7-HEALTH
Record Number: 99759
Last updated on: 2017-05-26
[PROJECT] PANCARESURFUP - PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies
ID: 257505
Start date: 2011-02-01, End date: 2017-01-31
Over the last 40 years, treatment for childhood and adolescent cancer has improved greatly; 5- year survival after childhood cancer is now 80% in developed countries. Approximately 1 individual in 750 of young adults is now a childhood cancer survivor. Epidemiologic data on t...
Programme: FP7-HEALTH
Record Number: 97692
Last updated on: 2017-05-29
List retrieved on: 2017-08-02
